Up-regulation of ribosome biogenesis by MIR196A2 genetic variation promotes endometriosis development and progression
article
OA: gold
CC0
⤵ 15 in-corpus citations
Abstract
// Cherry Yin-Yi Chang 1, 2, * , Ming-Tsung Lai 3, * , Yi Chen 4, * , Ching-Wen Yang 5, 6 , Hui-Wen Chang 7 , Cheng-Chan Lu 5 , Chih-Mei Chen 4 , Carmen Chan 4 , Ching Chung 4 , Chun-Cheng Tseng 6 , Tritium Hwang 6 , Jim Jinn-Chyuan Sheu 4, 6, 8, 9 , Fuu-Jen Tsai 4, 10 1 Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan 2 Institute of Environmental Health, China Medical University, Taichung, Taiwan 3 Department of Pathology, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan 4 Human Genetic Center, China Medical University Hospital, Taichung, Taiwan 5 The Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan 6 Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan 7 School of Medicine, China Medical University, Taichung, Taiwan 8 School of Chinese Medicine, China Medical University, Taichung, Taiwan 9 Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan 10 School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung, Taiwan * These authors have contributed equally to this work Correspondence to: Jim Jinn-Chyuan Sheu, email: [email protected] Fuu-Jen Tsai, email: [email protected] Keywords: ribosome biogenesis, MIR196A2, polymorphism, endometriosis, ovarian cancer Received: February 06, 2016 Accepted: August 09, 2016 Published: September 15, 2016 ABSTRACT Aberrant miRNA expression has been reported in endometriosis and miRNA gene polymorphisms have been linked to cancer. Because certain ovarian cancers arise from endometriosis, we genotyped seven cancer-related miRNA single nucleotide polymorphisms (MiRSNPs) to investigate their possible roles in endometriosis. Genetic variants in MIR196A2 (rs11614913) and MIR100 (rs1834306) were found to be associated with endometriosis development and related clinical phenotypes, such as infertility and pain. Downstream analysis of the MIR196A2 risk allele revealed upregulation of rRNA editing and protein synthesis genes, suggesting hyper-activation of ribosome biogenesis as a driving force for endometriosis progression. Clinical studies confirmed higher levels of small nucleolar RNAs and ribosomal proteins in atypical endometriosis lesions, and this was more pronounced in the associated ovarian clear cell carcinomas. Treating ovarian clear cells with CX5461, an RNA polymerase I inhibitor, suppressed cell growth and mobility followed by cell cycle arrest at G2/M stage and apoptosis. Our study thus uncovered a novel tumorigenesis pathway triggered by the cancer-related MIR196A2 risk allele during endometriosis development and progression. We suggest that anti-RNA polymerase I therapy may be efficacious for treating endometriosis and associated malignancies.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (69)
- BMPR1B Up-Regulation via a miRNA Binding Site Variation Defines Endometriosis Susceptibility and CA125 Levels via openalex
- Endometriosis in monozygotic twins via openalex
- Functional MicroRNA Involved in Endometriosis via openalex
- Heritability and Molecular Genetic Studies of Endometriosis via openalex
- HOX gene expression is altered in the endometrium of women with endometriosis via openalex
- Immunobiology of endometriosis via openalex
- Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis via openalex
- MicroRNA-Regulated Pathways Associated with Endometriosis via openalex
- MicroRNA Signature and Regulatory Functions in the Endometrium during Normal and Disease States via openalex
- Modern concepts of endometriosis. Classification and its consequences for therapy. via openalex
- Molecular genetic evidence that endometriosis is a precursor of ovarian cancer via openalex
- Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis via openalex
- Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review). via openalex
- Recent Advances in Endometriosis With Emphasis on Pathogenesis, Molecular Pathology, and Neoplastic Transformation via openalex
- Research Resource: Gene Expression Profile for Ectopic Versus Eutopic Endometrium Provides New Insights into Endometriosis Oncogenic Potential via openalex
- The role of microRNAs in endometriosis and associated reproductive conditions via openalex
- W2009851083 via openalex
- W2025669441 via openalex
- W2026697437 via openalex
- W2028058995 via openalex
- W2032149953 via openalex
- W2033887699 via openalex
- W2038437697 via openalex
- W2043841998 via openalex
- W2049868101 via openalex
- W2060869276 via openalex
- W2060913442 via openalex
- W2062993008 via openalex
- W2066151767 via openalex
- W2076591428 via openalex
- W2079208971 via openalex
- W2092869829 via openalex
- W2095125813 via openalex
- W2095571230 via openalex
- W2098571862 via openalex
- W2099396995 via openalex
- W2113570557 via openalex
- W2115894077 via openalex
- W2116588813 via openalex
- W2129104457 via openalex
- W2131918846 via openalex
- W2133139112 via openalex
- W2142140970 via openalex
- W2146033936 via openalex
- W2148763013 via openalex
- W2149848115 via openalex
- W2152091242 via openalex
- W2156538352 via openalex
- W2157876956 via openalex
- W2164385268 via openalex
- W2314033693 via openalex
- W4211081176 via openalex
- W45534775 via openalex
- W6659045709 via openalex
- W1484459469 via openalex
- W1539959559 via openalex
- W1869558150 via openalex
- W1964762016 via openalex
- W1971460830 via openalex
- W1974756790 via openalex
- W1975451104 via openalex
- W1981188497 via openalex
- W1981627455 via openalex
- W1983200597 via openalex
- W1985122162 via openalex
- W1985821091 via openalex
- W1997337693 via openalex
- W2006030377 via openalex
- W2006466548 via openalex
Cited by (15)
- Diagnostic accuracy of non-coding RNA for detecting endometriosis: A systematic review and meta-analysis 2025
- Genetic factors involved in the co‑occurrence of endometriosis with ankylosing spondylitis (Review) 2023
- Translational aspects of the endometriosis epigenome 2023
- Genetic variations in UCA1, a lncRNA functioning as a miRNA sponge, determine endometriosis development and the potential associated infertility via regulating lipogenesis 2022
- A More Diverse Cervical Microbiome Associates with Better Clinical Outcomes in Patients with Endometriosis: A Pilot Study 2022
- Ribosome Biogenesis Serves as a Therapeutic Target for Treating Endometriosis and the Associated Complications 2022
- A More Diverse Cervical Microbiome Associates with Better Clinical Outcomes in Patients with Endometriosis 2021
- Genetic impacts on thermostability of onco-lncRNA HOTAIR during the development and progression of endometriosis 2021
- MicroRNA variants in endometriosis and its severity 2021
- Microbiome of the lower genital tract in Chinese women with endometriosis by 16s-rRNA sequencing technique: a pilot study 2020
- Endometriosis-associated ovarian cancer: What have we learned so far? 2019
- 60S acidic ribosomal protein P1 (RPLP1) is elevated in human endometriotic tissue and in a murine model of endometriosis and is essential for endometriotic epithelial cell survival <i>in vitro</i> 2019
- A Systematic Review and Bioinformatics Study on Genes and micro-RNAs Involving the Transformation of Endometriosis into Ovarian Cancer 2019
- Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis 2018
- Translational Aspects of the Endometriosis Epigenome 2018
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:49.724109+00:00
License: CC0
· commercial use OK